Artificial intelligence can cut the diagnosis of blood clots in the lungs to a few minutes, instead of hours. And an ...

Thrombolex, Inc., a developer of treatments for arterial and venous thromboembolic diseases, announced the publication of the resu ...

Endovascular Engineering (E2) has completed enrolment of subjects in the pivotal cohort of its ENGULF trial, involving the Hēlo PE Thrombectomy System. The investigational device exemption study was ...

Endovascular Engineering, Inc. (E2) announced the completion of patient enrollment in the pivotal cohort of the ENGULF investigati ...

Boehringer Ingelheim has a second positive trial under its belt for nerandomilast in pulmonary fibrosis, setting up regulatory filings. The new data from the 1,178-patient FIBRONEER-ILD study ...

Find the latest information on Nasdaq CTA Cybersecurity Index (NQCYBRT), including data, charts, related news, and more from Nasdaq.com ...